| Vizoso FJ, Corte MD, Alvarez A, Garcia I, del Casar JM, Bongera M, Gonzalez LO, Garcia-Muniz JL, Allende MT. Membranous levels of c-erbB-2 oncoprotein in gastric cancer: their relationship with clinicopathological parameters and their prognostic significance. Int J Biol Markers. 2004 Oct-Dec;19(4):268-74.Fernandez JC, Vizoso FJ, Corte MD, Gava RR, Corte MG, Suarez JP, Garcia-Muniz JL, Garcia-Moran M. CD44s expression in resectable colorectal carcinomas and surrounding mucosa. Cancer Invest. 2004;22(6):878-85.Alvarez ML, Gonzalez LO, Barbon JJ, Astudillo A, Vizoso FJ. Expression and clinical significance of pepsinogen C in uveal melanomas. Int J Biol Markers. 2004 Jul-Sep;19(3):240-4.Vizoso FJ, Fernandez JC, Corte MD, Bongera M, Gava R, Allende MT, Garcia-Muniz JL, Garcia-Moran M. Expression and clinical significance of CD44V5 and CD44V6 in resectable colorectal cancer. J Cancer Res Clin Oncol. 2004 Nov;130(11):679-86. Epub 2004 Aug 06.Del Casar JM, Vizoso FJ, Abdel-Laa O, Sanz L, Martin A, Daniela Corte M, Bongera M, Garcia Muniz JL, Fueyo A. Prognostic value of cytosolyc cathepsin D content in resectable gastric cancer. J Surg Oncol. 2004 Apr 1;86(1):16-21.Vizoso FJ, del Casar JM, Corte MD, Garcia I, Corte MG, Alvarez A, Garcia-Muniz JL. Significance of cytosolic hyaluronan levels in gastric cancer. Eur J Surg Oncol. 2004 Apr;30(3):318-24.Alvarez ML, Barbon JJ, Gonzalez LO, Lamelas ML, Vazquez J, Vizoso FJ. Expression of two androgen-induced proteins (pepsinogen C and apolipoprotein d) in epithelial skin cancers of the eyelids. Ophthalmologica. 2004 Mar-Apr;218(2):115-9.Vizoso FJ, Fagilde MC, Corte MD, Corte MG, Gava R, Bongera M, Allende MT, Garcia-Muniz JL. Cytosolic levels of an estrogen-induced breast cancer-associated peptide (TFF1/pS2) in colorectal cancer: clinical significance and relationship with steroid receptors. Int J Biol Markers. 2003 Oct-Dec;18(4):301-10.Mulero M, Fernandez Raigoso P, Vazquez J, Lamelas ML, Corte D, Allende MT, Rodriguez JC, Vizoso F. [Clinical significance of tumor content of epidermal growth factor receptor in breast cancer] Rev Esp Med Nucl. 2003 Nov;22(6):386-94.Garcia I, del Casar JM, Corte MD, Allende MT, Garcia-Muniz JL, Vizoso F. Epidermal growth factor receptor and c-erbB-2 contents in unresectable (UICC R1 or R2) gastric cancer. Int J Biol Markers. 2003 Jul-Sep;18(3):200-6. |
